Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of ($0.46) per share and revenue of $2.40 million for the quarter. Parties may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, November 12, 2026 at 4:00 PM ET.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The firm had revenue of $1.44 million during the quarter, compared to analysts’ expectations of $1.90 million.
Arcadia Biosciences Trading Down 1.2%
Shares of NASDAQ RKDA opened at $0.16 on Tuesday. The stock has a fifty day simple moving average of $0.33 and a two-hundred day simple moving average of $1.01. Arcadia Biosciences has a 1-year low of $0.11 and a 1-year high of $4.18. The firm has a market cap of $375,960.00, a price-to-earnings ratio of -0.03 and a beta of 0.56.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Arcadia Biosciences in a research report on Tuesday, September 22nd. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock has an average rating of “Sell”.
Check Out Our Latest Report on Arcadia Biosciences
About Arcadia Biosciences
Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications.
Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.
Read More
- Five stocks we like better than Arcadia Biosciences
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
